Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Blood (2021) 137 (20): 2838–2847.

https://doi.org/10.1182/blood.2020010529

Published: 2021

Includes: Supplemental data

Journal Articles

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry

Dimitrios Giannis, MDMSc, Steven L. Allen, MD, Anne Davidson, MD, Galina S. Marder, MD, Sarah Flint, MD, David Garrett, MD, Richa Thakur, MD, Matthew Snyder, DO, Cristina Ghiuzeli, MD, Thomas G. McGinn, MD MPH, Karina W. Davidson, PhD MASc, Michael Qiu, MD PhD, Matthew Barish, MD, Alex C. Spyropoulos, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-141901

Published: 2020

Journal Articles

Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Andrea J. Darzi, Samer G. Karam, Rana Charide, Itziar Etxeandia-Ikobaltzeta, Mary Cushman, Michael K. Gould, Lawrence Mbuagbaw, Frederick A. Spencer, Alex C. Spyropoulos, Michael B. Streiff, Scott Woller, Neil A. Zakai, Federico Germini, Marta Rigoni, Arnav Agarwal, Rami Z. Morsi, Alfonso Iorio, Elie A. Akl, Holger J. Schünemann

Blood (2020) 135 (20): 1788–1810.

https://doi.org/10.1182/blood.2019003603

Published: 2020

Includes: Supplemental data

Journal Articles

Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study

Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MBBS, MSc, MD, Jeffrey I. Weitz, MD, Walter Ageno, Yoriko De Sanctis, MS, Wentao Lu, PhD, Jianfeng Xu, PhD, John Albanese, BS, MBA, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Theodore E. Spiro, MD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 163.

https://doi.org/10.1182/blood-2019-122934

Published: 2019

Journal Articles

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Alex C. Spyropoulos, MD, Gary E. Raskob, PhD, Alexander T Cohen, MBBS, MSc, MD, Walter Ageno, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Concetta Lipardi, MD PhD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 2441.

https://doi.org/10.1182/blood-2019-122930

Published: 2019

Journal Articles

Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial

Alex C. Spyropoulos, MD, Walter Ageno, Gregory W. Albers, MD, C. Gregory Elliott, MD, Jonathan L. Halperin, MD, William R. Hiatt, Gregory Maynard, MD, P. Gabriel Steg, MD, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Gary E. Raskob, PhD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 3669.

https://doi.org/10.1182/blood-2019-122621

Published: 2019

Journal Articles

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies

Alex C. Spyropoulos, MD, Concetta Lipardi, MD PhD, Alexander T Cohen, MBBS, MSc, MD, Biljana Vučković, MD PhD, Jianfeng Xu, PhD, Wentao Lu, PhD, Theodore E. Spiro, MD, Elliot S. Barnathan, MD, Gary E. Raskob, PhD

Blood (2019) 134 (Supplement_1): 3671.

https://doi.org/10.1182/blood-2019-122945

Published: 2019

Journal Articles

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

Blood (2018) 132 (Supplement 1): LBA-5.

https://doi.org/10.1182/blood-2018-120770

Published: 2018

Journal Articles

Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Treatment Among Morbidly Obese Patients with Venous Thromboembolism

Alex C. Spyropoulos, MD, Veronica Ashton, MPH, Yen-Wen Chen, Bingcao Wu, Eric D. Peterson

Blood (2018) 132 (Supplement 1): 2537.

https://doi.org/10.1182/blood-2018-99-115144

Published: 2018

Journal Articles

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Jeffrey I. Weitz, MD, Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MD, Theodore E. Spiro, MD, Yoriko De Sanctis, MS, Jianfeng Xu, PhD, Eunyoung Suh, PhD, Wentao Lu, PhD, Concetta Lipardi, MDPhD, Elliot S. Barnathan, MD

Blood (2018) 132 (Supplement 1): 1236.

https://doi.org/10.1182/blood-2018-99-111911

Published: 2018

Journal Articles

Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism

Christine G. Kohn, BS, PharmD, Gary H. Lyman, MD MPH, FRCP, Jan Beyer-Westendorf, MD, Alex C. Spyropoulos, MD, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2017) 130 (Supplement 1): 3717.

https://doi.org/10.1182/blood.V130.Suppl_1.3717.3717

Published: 2017

Journal Articles

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?

Alex C. Spyropoulos, MD, Ron Preblick, PharmD, MPH, Jackie Kwong, PhD, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA

Blood (2015) 126 (23): 1126.

https://doi.org/10.1182/blood.V126.23.1126.1126

Published: 2015

Journal Articles

External Validation of a Risk Assesment Model for Bleeding Risk in Medical Patients: Findings from the Improve Investigators in a Tertiary Health System

Annie Press, David Rosenberg, MD MPH, Joanna Fishbein, Franak Batliwalla, MPH, Alex C. Spyropoulos, MD

Blood (2015) 126 (23): 748.

https://doi.org/10.1182/blood.V126.23.748.748

Published: 2015

Journal Articles

How I treat anticoagulated patients undergoing an elective procedure or surgery

Alex C. Spyropoulos, James D. Douketis

Blood (2012) 120 (15): 2954–2962.

https://doi.org/10.1182/blood-2012-06-415943

Published: 2012

Journal Articles

The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer

Alexander T Cohen, Theodore E Spiro, Paul Burton, Harry R Büller, Lloyd Haskell, Da-Yi Hu, Russell D Hull, Alexandre Mebazaa, Geno J Merli, Sebastian Schellong, Alex C Spyropoulos, Victor F Tapson

Blood (2011) 118 (21): 542.

https://doi.org/10.1182/blood.V118.21.542.542

Published: 2011

Journal Articles

Perioperative Heparin Bridging in Patients Receiving Oral Anticoagulation: Meta-Analysis of Bleeding and Thromboembolic Rates

Jovana Yudin, BSc, MD, Deborah Siegal, MSc, MD, Wendy Lim, MD, MSc, Scott Kaatz, MD, James Douketis, MD, FRCP, Alex C Spyropoulos

Blood (2011) 118 (21): 545.

https://doi.org/10.1182/blood.V118.21.545.545

Published: 2011

Journal Articles

Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Elective Surger or Procedure - the BRIDGE Trial: Design, Rationale and Clinical Implications

Alex C Spyropoulos, MD, James Douketis, MD, FRCP, Scott Kaatz, MD, Thomas L. Ortel, MD, PhD

Blood (2011) 118 (21): 4327.

https://doi.org/10.1182/blood.V118.21.4327.4327

Published: 2011

Journal Articles

Venous Thromboembolism Validation Study of the IMPROVE Risk Assessment Models in the Medical Patient (VTE-VALOURR),

Charles Edward Mahan, III, PharmD, Yang Liu, M Math, James D. Douketis, MD, Alexander G.G. Turpie, Undaleeb Dairkee, MD, Alex C Spyropoulos, MD

Blood (2011) 118 (21): 4218.

https://doi.org/10.1182/blood.V118.21.4218.4218

Published: 2011

Journal Articles

Venous Thromboembolism: A United States Cost Model for a Preventable and Costly Adverse Event,

Charles Edward Mahan, III, PharmD, Matt Borrego, RPH, Alex C Spyropoulos, MD

Blood (2011) 118 (21): 4224.

https://doi.org/10.1182/blood.V118.21.4224.4224

Published: 2011

Journal Articles

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model

Neil A. Goldenberg, Alex C. Spyropoulos, Jonathan L. Halperin, Craig M. Kessler, Sam Schulman, Alexander G. G. Turpie, Allan M. Skene, Neal R. Cutler, William R. Hiatt, for the Antithrombotic Trials Leadership and Steering Group

Blood (2011) 117 (7): 2089–2092.

https://doi.org/10.1182/blood-2010-09-308858

Published: 2011

NARROW

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry

Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Treatment Among Morbidly Obese Patients with Venous Thromboembolism

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?

External Validation of a Risk Assesment Model for Bleeding Risk in Medical Patients: Findings from the Improve Investigators in a Tertiary Health System

How I treat anticoagulated patients undergoing an elective procedure or surgery

The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer

Perioperative Heparin Bridging in Patients Receiving Oral Anticoagulation: Meta-Analysis of Bleeding and Thromboembolic Rates

Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Elective Surger or Procedure - the BRIDGE Trial: Design, Rationale and Clinical Implications

Venous Thromboembolism Validation Study of the IMPROVE Risk Assessment Models in the Medical Patient (VTE-VALOURR),

Venous Thromboembolism: A United States Cost Model for a Preventable and Costly Adverse Event,

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only